ATE239489T1

Composition containing pyrrolizidine-alkaloid-free petasites

Abstract

Petasite preparations without hepatotoxic, carcinogenic, cytostatic and/or mutagenic effect with a rapid and/or improved action are provided. The petasite extract is recovered from a plant and/or plant parts of the genus Petasites, the petasite extract being free of pyrrolizidine alkaloids, and in which magnesium and/or other pharmacologically and/or physiologically active substances are optionally added. The extract is effective in treating a wide variety of indications, such as gastrointestinal diseases, asthmas, pollinosis, dysmenorrhea, eczemas, migraines, psoriasis and high blood pressure.

Term

Term ended

Projected expiry passed 29 June 2019, 7.2 years ago.

  1. Priority
  2. Filed
  3. Published
  4. Projected expiry
  5. Today

14 members in 8 offices

This recordMember, by publication datePriority claim

Priority claims2

Priority claims
DocumentOfficeKindDate
19838848GermanyA
9904484European Patent Office (EPO)W

Members14

Family members, oldest first
DocumentOfficeKind
DE19838848A1GermanyA1
WO0012107A1World Intellectual Property Organization (WIPO)A1
AU4902299AAustraliaA
EP1107775A1European Patent Office (EPO)A1
JP2002523464AJapanA
US6551626B1United States of AmericaB1
EP1107775B1European Patent Office (EPO)B1
AT239489TAustriaT
ATE239489T1This recordAustriaT1
DE59905484D1GermanyD1
US2004018251A1United States of AmericaA1
ES2198926T3SpainT3
US7090871B2United States of AmericaB2
EP1107775B2European Patent Office (EPO)B2